Skip to main content

Cosmos Health Inc.

corporate_fare Company Profile

Cosmos Health Inc.

COSM·NASDAQ·Life Sciences·CIK 0001474167

Cosmos Health Inc., incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The company owns proprietary pharmaceutical and nutraceutical brands, manufactures and distributes healthcare products, and engages in research and development of innovative medicines and drug repurposing. It also operates a telehealth platform. Cosmos Health Inc. operates in the healthcare sector, specifically within the Pharmaceutical and Nutraceutical businesses. The company covers several process phases including research and development, manufacturing, marketing, sales, and distribution of products and services. Its operations include generic medicines, nutraceuticals, biocides, medical devices, novel oncology drugs, drug repurposing, and telehealth services. Generic medicines are pharmaceutical and therapeutic equivalents of branded products, marketed under their chemical names, and generally sold at lower prices. The company also operates in the global nutraceuticals market with its own brand. Nutraceuticals are orally consumed products containing at least one dietary ingredient, used for purposes such as immune system defense, energy, stress, and bones and joints.

Cosmos Health Inc. (NASDAQ:COSM) is a publicly traded company in the Life Sciences sector. Wiseek monitors COSM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • CEO Converts $120,000 Debt to Equity, Boosting Confidence
  • CEO Converts $175K Debt to Equity, Signaling Strong Confidence in Cosmos Health
  • Cosmos Health CEO Converts $220K Debt to Equity, Signaling Strong Confidence
  • CEO Converts Debt to Equity, Increasing Stake in Cosmos Health
  • CEO Converts $81K Debt to Equity, Signaling Strong Confidence

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$65.27M
Net Income
-$19.14M
Diluted EPS
-$0.63
Op. Cash Flow
-$8.45M
Free Cash Flow
-$8.5M
Gross Profit
$7.9M
Operating Income
-$16.7M
Cash & Equivalents
$715.67K
Debt / Equity
0.00×
Net Margin
-29.3%
Shares Outstanding
41.07M sh
Source: 10-K · filed 2026-04-15 · accession 0001477932-26-002278
$0.2126 +0.00% today
52-week range · as of 2026-06-12 $0.1952 – $1.32
Market cap
$13.04M
Volume
6.3M (3.2× avg)
3-mo avg 1.9M
Live data · 2026-06-14 07:25 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COSM - Filings & News (Page 3)

COSM
Feb 12, 2026, 2:20 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.3517
Real-time Price: $0.2126 info
Change: -$0.1391 (-40%) info
Market Cap: $13.036M info
COSM
Jan 21, 2026, 10:11 AM EST
Filing Type: 4
Importance Score:
9
Price at Filing: $0.5166
Real-time Price: $0.2126 info
Change: -$0.304 (-59%) info
Market Cap: $13.036M info
COSM
Jan 15, 2026, 9:40 AM EST
Filing Type: 4
Importance Score:
9
Price at Filing: $0.421
Real-time Price: $0.2126 info
Change: -$0.2084 (-50%) info
Market Cap: $13.036M info
COSM
Jan 13, 2026, 10:00 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.4961
Real-time Price: $0.2126 info
Change: -$0.2835 (-57%) info
Market Cap: $13.036M info
COSM
Jan 09, 2026, 11:43 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.5173
Real-time Price: $0.2126 info
Change: -$0.3047 (-59%) info
Market Cap: $13.036M info
COSM
Jan 08, 2026, 10:41 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.5214
Real-time Price: $0.2126 info
Change: -$0.3088 (-59%) info
Market Cap: $13.036M info
COSM
Jan 07, 2026, 1:01 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.2126 info
Change: -$0.2874 (-57%) info
Market Cap: $13.036M info